01 — At a Glance
The Government Fertiliser Story: If Chaos Was a P&L Statement
Let’s not sugarcoat it. FACT is in a state of controlled implosion. Q3 FY26 delivered ₹1,568 crore in revenue — a whopping 65% YoY spike thanks to better fertiliser demand. And then management managed to lose ₹68 crore in the same period. Not just zero profit. Not breakeven. A straight-up loss. The market, unbothered by economics, trades it at ₹681, giving it a market cap of ₹44,043 crore. That’s nearly the same as Bharati Airtel (₹44,500 crore), except Airtel actually makes money.
The Core Problem: Q3 FY26 saw a 65.1% jump in revenue, yet profit tanked to -₹68 crore (vs. -₹50 crore in Q2 FY26, and a loss of ₹67 crore in Q3 FY25). This isn’t a business cycle issue. This is structural. Operating margin: -3%. Interest coverage: 1.11x (anything below 1.5x is alarm bells). Debt-to-equity: 2.79x. The government put ₹3,837 crore of public debt into a company that’s losing money faster than farmers need fertiliser.
- Q3 FY26 Revenue₹1,568 Cr
- Q3 FY26 PAT-₹68 Cr
- 52-Week High / Low₹1,112 / ₹565
- EPS (TTM)₹0.43
- Book Value₹21.2
- Price to Book32.0x
- Return 6 Months-29.8%
- Return 1 Year+3.25%
- Dividend Yield0.03%
- Total Debt₹3,837 Cr
02 — Introduction: The Fertiliser Company That Fertilises Losses
Meet FACT: 82 Years Old, ₹44K Crore Valuation, ₹28 Crore Annual Profit
Fertilizers & Chemicals Travancore Limited (FACT) is India’s first large-scale fertiliser plant, set up in 1943 at Udyogamandal, Kochi. It’s a Department of Chemicals & Fertilizers undertaking — which is fancy government-speak for “it’s complicated.”
The company is 90% owned by the Government of India. The remaining 10% is scattered among DIIs, FIIs, and confused retail investors asking “why is the P/E 2,974?” (a valid question with no good answer). FACT manufactures Factamfos (complex fertilisers), Ammonium Sulphate, Caprolactam (nylon precursor), and imported fertilisers. Think of it as the country’s old-school fertiliser backbone — except the backbone has severe osteoporosis.
In FY25, FACT posted ₹41 crore in PAT. In FY26 (trailing twelve months), it’s down to ₹28 crore. That’s a decline of 32% year-on-year. Meanwhile, the government, as promoter, paid off ₹246 crore in interest costs — meaning every rupee of profit goes straight to servicing historical debt accumulated across decades of capex and subsidy regimes.
The company announced a new CMD (Shri S Sakthimani) on February 2, 2026. Great. Fresh leadership for a company with a ₹2.79x debt-to-equity ratio, operating margins swinging between -3% and +15%, and a business model that generates revenue but can’t seem to extract profit.
The Recent Twist: On February 4 & 6, 2026, the stock exchange sought “clarifications” from FACT on its Q3 FY26 results. This is regulator-speak for “your numbers are weird, please explain.” FACT complied on February 6. The core issue: Q3 revenue surged 65%, but the company managed to lose money. This is the opposite of how businesses should work.
03 — Business Model: The Fertiliser Paradox
It’s Simple Economics. So Why Doesn’t It Work?
FACT operates two main manufacturing hubs: Cochin Division and Ambalamedu (Ammonium Sulphate & storage). The installed capacity is monstrous — 633,500 MTPA of Factamfos, 225,000 MTPA of Ammonium Sulphate, 50,000 MTPA of Caprolactam. In FY23, the company sold 828,195 MT of Factamfos and 220,000 MT of Ammonium Sulphate. So the plants are running. Farmers are buying. What’s the problem?
The answer lies in three words: government-controlled pricing. India’s fertiliser sector operates under the Nutrient Based Subsidy (NBS) scheme. The government sets a maximum retail price. FACT manufactures and sells at this fixed price. But the cost of production — raw materials, energy, labour, debt servicing — is variable. Caprolactam and Ammonium Sulphate have better margins. Factamfos, the volume star, has razor-thin margins because it’s a mass-market crop fertiliser.
This worked when FACT was the only large producer. Today, FACT has competition. And FACT’s legacy cost structure (high fixed costs, pension liabilities, inefficient plants, debt overhang) means every unit sold erodes margins.
Q3 Revenue₹1,568 Cr+65% YoY
Q3 PAT-₹68 CrLoss
OPM-3%Negative
Factamfos Vol743k MT73% of revenue
The Capex Trap: FACT launched a ₹700 crore capex project to expand Factamfos production from 10 LMT to 14 LMT and projected turnover to ₹5,000 crore by FY25. That was 2018’s vision. Today, FY26 (TTM) revenue is ₹5,293 crore. Capex didn’t solve profitability. It just added fixed costs. Management expected a ₹5,000 crore revenue target to deliver profit. Instead, ₹5,293 crore is barely breakeven.
💬 What would you do if you inherited a government fertiliser plant with 90% ownership, 2.79x debt-to-equity, and ₹246 crore in annual interest costs? Drop your restructuring plan in the comments.
04 — Financials: The Horror Show
Q3 FY26: Revenue Up 65%. Profit Down 949%.
Result Type: Quarterly Results | Q3 FY26 EPS: ₹-1.05 | TTM (Trailing Twelve Months) EPS: ₹0.43
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 1,568 | 949 | 1,629 | +65.1% | -3.7% |
| Operating Profit | -43 | 32 | 39 | -234% | -210% |
| OPM % | -3% | 3% | 2% | -600 bps | -500 bps |
| PAT | -68 | 8 | 21 | -949% | -424% |
| EPS (₹) | -1.05 | 0.12 | 0.32 | -975% | -428% |
The Math Doesn’t Lie: Revenue jumped 65.1% YoY. Operating profit fell from ₹32 crore to -₹43 crore (a -234% swing). The reason? Expenses grew faster than revenue. Q3 FY26 expenses hit ₹1,611 crore against ₹1,568 crore revenue. That’s an 103% cost-to-revenue ratio. The company is spending ₹1.03 for every rupee earned. And this happens in the peak fertiliser season (October-December). Imagine what the off-season looks like.
05 — Valuation: The Twilight Zone
Fair Value Range: Somewhere Between ₹0 and Infinity
Join 10,000+ investors who read this every week.
